Anti-EBAG9 Antibody

This rabbit polyclonal IgG preparation from Antibodies.com targets EBAG9, a tumor-associated antigen also referred to as RCAS1 that was originally characterized through its interaction with the estrogen receptor. The unconjugated antibody is supplied as a 50 µl aliquot and is validated for Western blot and immunohistochemistry workflows on samples derived from human, mouse, and rat tissues.

EBAG9 expression is frequently examined in cancer research contexts, where its reported modulation of immune cell activity and induction of apoptosis in activated lymphocytes make it a useful marker for studies of tumor immune evasion. The polyclonal format offers recognition of multiple epitopes on the EBAG9 protein, which can be advantageous when probing tissue sections or immunoblots for endogenous expression patterns. Researchers commonly apply this reagent to characterize EBAG9 levels in cultured cell lines and primary tumor material, and to compare expression across normal versus malignant specimens in translational investigations. Storage at refrigerated temperatures preserves activity for routine bench use, and the small pack size suits pilot experiments and antibody panel screening before scaling to larger studies.